Facebook Linkedin RSS Twitter Youtube
Home 2024

Cancer drug discovery

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs
Drug Discovery

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic
Artificial Intelligence

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic

JAK Attack: Ajax Takes Aim at Myelofibrosis
Cancer

JAK Attack: Ajax Takes Aim at Myelofibrosis

StockWatch: Like a Bolt from the Blue, Cancer Drug Developer Nosedives
Cancer

StockWatch: Like a Bolt from the Blue, Cancer Drug Developer Nosedives

Novartis to Acquire Mariana for Up to $1.75B, Expanding Radiopharma Pipeline
Drug Discovery

Novartis to Acquire Mariana for Up to $1.75B, Expanding Radiopharma Pipeline

The Upside Down: Delphia Therapeutics Launches to Treat Cancer with Activation Lethality
Cancer

The Upside Down: Delphia Therapeutics Launches to Treat Cancer with Activation Lethality

Gene Network Interactions Shed Insight into Breast Cancer Onset and Development
Cancer

Gene Network Interactions Shed Insight into Breast Cancer Onset and Development

Dupixent Redux? Synthekine, Sanofi Partner on Cytokine Therapies
Cancer

Dupixent Redux? Synthekine, Sanofi Partner on Cytokine Therapies

Cancer Drug Discovery May Accelerate as Many Overlooked Targets Prioritized
Cancer

Cancer Drug Discovery May Accelerate as Many Overlooked Targets Prioritized

Pancreatic Cancer Drug Discovery Gets Boost from Organoid Screening System
Cancer

Pancreatic Cancer Drug Discovery Gets Boost from Organoid Screening System

123...18Page 1 of 18
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.